tiprankstipranks
Trending News
More News >
Crispr Therapeutics (CRSP)
NASDAQ:CRSP

Compare Crispr Therapeutics AG (CRSP) vs. Competitors

Compare
10,758 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Crispr Therapeutics AG
$56.40
$5.37B
36.59%
12 Buy
7 Hold
0 Sell
Moderate Buy
Intellia Therapeutics
$10.52
$1.22B
-12.48%
9 Buy
12 Hold
1 Sell
Moderate Buy
Apellis Pharmaceuticals
$26.26
$3.32B
88.45
-20.42%
9 Buy
5 Hold
0 Sell
Moderate Buy
Beam Therapeutics
$28.00
$2.84B
-6.31
4.48%
10 Buy
3 Hold
0 Sell
Strong Buy
Legend Biotech
$23.03
$4.25B
-17.64
-29.72%
10 Buy
1 Hold
0 Sell
Strong Buy
Kymera Therapeutics
$74.98
$5.92B
-20.85
85.04%
21 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CRSP
Crispr Therapeutics AG
56.40
17.55
45.17%
NTLA
Intellia Therapeutics
10.52
0.47
4.68%
APLS
Apellis Pharmaceuticals
26.26
-2.33
-8.15%
BEAM
Beam Therapeutics
28.00
2.46
9.63%
LEGN
Legend Biotech
23.03
-9.47
-29.14%
KYMR
Kymera Therapeutics
74.98
37.76
101.45%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts